HitGen featuring 200㎡ BSL-2 laboratories, SPF animal facilities, and NGS platforms. Through the strategic convergence of cutting-edge facilities and systematic research capabilities, covering early discovery to preclinical development services.
HitGen offers high-quality sequencing services powered by two Illumina platforms (NextSeq2000 and NovaSeq6000) and one MGI platform (MGISEQ-2000), supported by 8 versatile flow cell types. Our flexible solutions cover a wide range of sequencing capacities, from 400M to 10,000M reads, tailored to your specific needs. With an average Q30 score exceeding 92% and a turnaround time of under two days, we deliver both speed and reliability for your research. In addition to DNA-encoded library (DEL) sequencing, we also provide multi-omics sequencing and data analysis services.
NGS flow chart
NGS capabilities
Platform | NextSeq2000 | NovaSeq6000 | MGISEQ2000 | |||||
Chips | P2 | P3 | SP | S1 | S2 | S4 | FCS | FCL |
# of Lanes | 1 | 2 | 2 | 2 | 2 | 4 | 2 | 4 |
# of Reads | 400M | 1200M | 800M | 1600M | 4100M | 10000M | 550M | 1500M |
NGS applications
1. DEL related: Naïve DEL, Pooled DEL selection (1T DEL, OpenDEL, Customer DEL, etc.)
2. Multiomics sequencing and analysis
2.1 Personalized Cancer Medicine Therapy
2.2 Meta-genomics sequencing
2.3 Exome sequencing
2.4 Transcriptome sequencing
2.5 Epigenetic Application
2.6 Pharmacogenomics Application
HitGen NGS Sequencing Advantages
• Proven Expertise in DNA-Encoded Library (DEL) Sequencing
– Mature technology with validated success cases
• Diverse Sequencing Applications and Extensive Project Experience
– Tailored solutions for a wide range of research needs
• Pharmacogenomics Sequencing to Accelerate Drug Discovery
– Data-driven support for novel therapeutic development
We use cookies to provide a better web experience.
By using our site, you acknowledge our use of cookies and please read our Cookie Notice for
More information